Profil
Richard A. Morgan is currently the Director at the American Society of Gene & Cell Therapy.
Prior to this, he was the Senior Vice President-Immunogenetics at Editas Medicine, Inc. from 2018 to 2021.
He received his undergraduate degree from Brandeis University and his doctorate from The Johns Hopkins University.
Postes actifs de Richard A. Morgan
| Sociétés | Poste | Début |
|---|---|---|
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Directeur/Membre du Conseil | - |
Anciens postes connus de Richard A. Morgan
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Corporate Officer/Principal | 01/02/2021 |
Formation de Richard A. Morgan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
















